Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

About this Publication
Title
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Pubmed ID
11189691 (View this publication on the PubMed website)
Publication
Control Clin Trials. 2000 Dec; Volume 21 (Issue 6 Suppl): Pages 400S-406S
Authors

Miller AB, Yurgalevitch S, Weissfeld JL, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team

Abstract

The procedures that have been adopted in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial are described. These procedures have been designed to ensure unbiased decisions on the underlying cause of death for all confirmed or suspected PLCO cancers. A death review committee with a nonvoting chair and three experienced reviewers as members has been appointed. After an initial pilot study, the procedures have been instituted and are working well.

Related CDAS Studies